Navigation Links
UIC study finds girls aware of HPV vaccine's benefits
Date:10/15/2009

Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections.

The study, conducted by University of Illinois at Chicago and University of Chicago researchers, appears online and in the November issue of the Journal of Adolescent Health.

The findings are reassuring in that girls and young women did not think that the vaccine provided benefits beyond protecting them from HPV, said Dr. Rachel Caskey, assistant professor of pediatrics and general internal medicine at UIC and lead author of the study. "We also found that they did not think that they could stop cervical cancer screening, or pap smears, which is critical."

Researchers used a national sample, representative of the U.S. population, to conduct an online survey of more than 1,000 females ages 13 to 26.

The data provide some of the first nationally representative estimates of both adolescents' and young women's adoption of the HPV vaccine, barriers to vaccination, and sources of information about HPV and the HPV vaccine, according to the researchers.

Knowledge about the HPV virus itself ran the gamut, said Caskey. Some people knew absolutely nothing and a few people were moderately informed. Knowledge about the HPV vaccine, however, was better.

"Messages about the vaccine are getting across, though they are not including messages about the virus itself," said Caskey.

The HPV vaccine is likely to provide the greatest benefit to those who receive it prior to HPV exposure, but nearly 30 percent of the unvaccinated girls reported not getting the vaccine because they were not currently sexually active.

The study found that the respondents' primary source of information about the HPV vaccine was advertisements for the vaccine, marketed as Gardasil (61 percent), healthcare providers (35 percent) and family members (31 percent).

It is probably ideal when family and doctors can be the primary providers of information, said Caskey, but that is not realistic today due to the influence of the media.

"Many girls are realizing, 'this is a vaccine I should get, it prevents cervical cancer, it doesn't protect me from other things, but I don't really know much about the virus,'" said Caskey.

The researchers also found that cost was not a barrier for many participants, particularly younger girls.

When asked about other participatory guidance topics, such as sex, alcohol, and drugs, less than half of the participants said their doctor ever talked to them about these issues.

Arguably, said Caskey, these issues should be the main topic of conversation during a regular visit to a healthcare provider for girls and young women.

Consistent with other studies about vaccine adoption, the researchers found that 30 percent of 13- to 17-year-olds and 9 percent of 18- to 26-year-olds reported receiving at least one HPV injection.


'/>"/>

Contact: Sherri McGinnis Gonzlez
smcginn@uic.edu
312-996-8277
University of Illinois at Chicago
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Cable Network (PCN) during the summer of 2016. The program was made possible ... the United States Department of Health and Human Services Administration. The broadcast, ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio , founder ... national #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer ... Gives Back initiative, and we’re very pleased with the participation in every ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims to redefine ... are both engaging and easy to use. Coming off the heels of a ... today its plans to roll out new AI-powered self-service enhancements to help organizations ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... -- External Defibrillators, Implantable Cardioverter Defibrillators, ... Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, ... The global defibrillators market is expected ... 2016-2020 and CAGR of 5.1% from 2020-2026. The ... of 5.2% from 2016 to 2026. The market ...
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... forecasts the global optical transceiver market to grow at a CAGR ... covers the present scenario and the growth prospects of the global ... report considers the revenue generated from the shipment of optical transceivers ...
(Date:12/9/2016)... Dec. 9, 2016 Mitsubishi Tanabe Pharma Corporation ... Representative Director, CEO: Dr. Masayuki Mitsuka ) has ... (ALS) given edaravone intravenously in 10-14 day cycles for ... by the ALS Functional Rating Scale-Revised (ALSFRS-R). The data ... on ALS/MND in Dublin, Ireland . ...
Breaking Medicine Technology: